TNFSF11 and postmenopausal osteoporosis: Lymphocytes have been implicated in receptor activator of nuclear factor kappa-B ligand (RANKL) production and bone loss associated with skeletal pathologies that include postmenopausal osteoporosis(23), inflammatory rheumatoid arthritis(24) and alveolar bone loss associated with periodontal infection(25).